The IPKat has just received volume 1, issue 1, of two new titles: Advertising, Marketing & Branding Law Journal and Life Sciences Law & Business, published six times a year by Legalease. At £295 and £315 respectively, these slim magazines (24 pages, inclusive of Legalease's own advertisements) seem quite dear. However, they both look quite promising in terms of their content. Advertising, Marketing & Branding Law Journal reminds the IPKat of the fate of the late and not greatly lamented Journal of Advertising and Marketing Law and Practice, which endured a brief and sporadic existence in the UK in the 1980s. The market for literature on this subject is surely larger and more sophisticated now than it was then, but titles in the field of advertising and marketing law have, sadly, never really thrived. Life Sciences Law & Business looks as though it may have a brighter and more profitable future, since its target market includes pharma and biotech companies.
NEW KIDS ON THE BLOCK
![NEW KIDS ON THE BLOCK]()
Reviewed by Jeremy
on
Tuesday, May 11, 2004
Rating:
Follow the IPKat on LinkedIn 
![[Book Review] The Protection of Traditional Knowledge at the Frontiers of Drug Discovery](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjf_htBaZqD2QUqdkN4UF7X6fhzdhKifpCQU9km3Bhkr538P9WRK9RJN05CT-o5_nilT0Q4jbRUjNXMY8AKGvRdjqy5QFn537o_8DuaDYPIkXEHyyX1_xz0kIEuCT0vhOkqM4Y7fmF4u5K6zv7pThVFds8J0EI3rr-G9FV-vFQqMo67ggzXtrcoMg/s72-c/20250218_142221.jpg)
![[Guest Post] [Conference Report] – Botticelli v Warhol – 2025 Cultural Heritage Conference in Florence (Day 2)](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj8tCb0iuaVNke-rHsXXqDZ7PCAGkS_o4RtyhrJ_QY4JsY-WSltt05LQRHwEYHJg2J8YjK6kqpSDHm9_nOGjax8YqCtrzZqV3wGN98-Vy52fnKgZyZngU9wQTHDeU3YiUHji010rinVFVOMlR_0SxHA76gMQRUuLe7_mB_-7IJHTTuLtyQDZ5GLag/s72-w151-c-h200/1.jpg)
Posts
No comments:
All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.
It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.
Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html